Society3 years ago
Covid-19 pill developers aim to top Merck, Pfizer efforts
As Merck & Co and Pfizer Inc prepare to report clinical trial results for experimental Covid-19 antiviral pills, rivals are lining up with what they hope will prove to be more potent and convenient oral treatments of their own.